Plasma membrane expression of ZNF185 is a prognostic factor in pancreatic ductal carcinoma

被引:4
|
作者
Furukawa, Daisuke [1 ,2 ,3 ]
Chijiwa, Tsuyoshi [4 ]
Matsuyama, Masahiro [3 ]
Mukai, Masaya [5 ]
Matsuo, Ei-Ichi [6 ]
Nishimura, Osamu [7 ]
Kawai, Kenji [4 ]
Suemizu, Hiroshi [4 ]
Nakagohri, Toshio [3 ]
Ozawa, Soji [3 ]
Shimada, Kazuaki [8 ]
Hiraoka, Nobuyoshi [1 ,2 ]
Nakamura, Masato [9 ]
机构
[1] Natl Canc Ctr, Res Inst, Div Pathol & Clin Labs, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Res Inst, Div Mol Pathol, Tokyo 1040045, Japan
[3] Tokai Univ, Sch Med, Dept Surg, Isehara, Kanagawa 2591193, Japan
[4] Cent Inst Expt Anim, Kawasaki, Kanagawa 2100821, Japan
[5] Tokai Univ, Hachioji Hosp, Dept Surg, Hachioji, Tokyo 1920032, Japan
[6] Shimadzu Co Ltd, Global Applicat Dev Ctr, Kyoto 6048511, Japan
[7] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan
[8] Natl Canc Ctr, Res Inst, Div Hepatobiliary & Pancreat Surg, Tokyo 1040045, Japan
[9] Tokai Univ, Sch Med, Dept Regenerat Med, Isehara, Kanagawa 2591193, Japan
关键词
zinc finger protein 185; pancreatic ductal carcinoma; prognosis; hematogenous metastasis; subcellular location; LIVER METASTASIS; COLON-CANCER; PAXILLIN; GEMCITABINE; PROTEIN;
D O I
10.3892/ol.2017.6633
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal carcinoma (PDC) is one of the major causes of cancer-associated mortality globally due to its high potential for distant metastasis. To understand hematogenous metastasis, the molecular expression profiles of weak metastatic PDC cell subline BxPC-3 and highly liver-metastatic cell subline LM-BxPC-3 were compared, and zinc finger protein 185 (ZNF185) was identified as a molecule that is upregulated in LM-BxPC-3 cells. The aim of the present study was to evaluate the clinicopathological significance of ZNF185 in PDC. Using immunohistochemistry, ZNF185 expression was investigated in 182 patients with PDC, in association with numerous clinicopathological variables. The expression profile of ZNF185 was also characterized using xenograft models. In contrast to parent BxPC-3 cells in subcutaneous transplanted tumor foci, which only expressed ZNF185 on their plasma membrane (m)ZNF185, LM-BxPC-3 cells in liver-metastatic foci that were formed subsequent to transplantation all expressed cytoplasmic (c)ZNF185. Additionally, 51% of the cells at the periphery of the tumor foci expressed mZNF185. Expression of cZNF185, and of mZNF185 and cZNF185 combined was identified in 93 and 39% of clinical patients with PDC, respectively. Patients with mZNF185-negative and-positive PDC exhibited a median survival time of 30.2 months and 21.3 months, respectively. Multivariate analysis indicated that the expression of mZNF185 is closely associated with a shorter overall survival time. Increased marked venous invasion was more prevalent in patients who were mZNF185-positive, as compared with patients who were mZNF185-negative. These data suggest that the expression of mZNF185 is an independent and unfavorable prognosticator in patients with PDC. The results suggested that the amount and subcellular location of ZNF185 are correlated with the position of the cancer cells expressing it within the nests. Additionally, the subcellular location of ZNF185 may be important to its biological function.
引用
收藏
页码:3633 / 3640
页数:8
相关论文
共 50 条
  • [1] HEATR1 Deficiency Promotes Chemoresistance via Upregulating ZNF185 and Downregulating SMAD4 in Pancreatic Cancer
    Fang, Yuan
    Han, Xu
    Li, Jianang
    Kuang, Tiantao
    Lou, Wenhui
    JOURNAL OF ONCOLOGY, 2020, 2020
  • [2] ZNF185 is a p63 target gene critical for epidermal differentiation and squamous cell carcinoma development
    Smirnov, Artem
    Lena, Anna Maria
    Cappello, Angela
    Panatta, Emanuele
    Anemona, Lucia
    Bischetti, Simone
    Annicchiarico-Petruzzelli, Margherita
    Mauriello, Alessandro
    Melino, Gerry
    Candi, Eleonora
    ONCOGENE, 2019, 38 (10) : 1625 - 1638
  • [3] Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma
    Tobita, K
    Kijima, H
    Dowaki, S
    Oida, Y
    Kashiwagi, H
    Ishii, M
    Sugio, Y
    Sekka, T
    Ohtani, Y
    Tanaka, M
    Inokuchi, S
    Makuuchi, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 21 (06) : 1189 - 1195
  • [4] Intratumoural expression of dihydropyrimidine dehydrogenase is an independent prognostic factor in resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine
    Blomstrand, Hakon
    Bodarve, Malin
    Groth, Fredrik
    Naredi, Peter
    Sund, Malin
    Vilhav, Caroline
    Green, Henrik
    Bjornsson, Bergthor
    Ohlund, Daniel
    Lindblad, Stina
    Franklin, Oskar
    Elander, Nils O.
    ONCOLOGY LETTERS, 2025, 29 (02)
  • [5] Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma
    Mahipal, Amit
    Mcdonald, Mary J.
    Witkiewicz, Agnieszka
    Carr, Brian I.
    MEDICAL ONCOLOGY, 2012, 29 (01) : 134 - 139
  • [6] Pancreatic intraepithelial neoplasia in the background of invasive ductal carcinoma of the pancreas as a prognostic factor
    Oda, Yasunori
    Aishima, Shinichi
    Morimatsu, Katsuya
    Shindo, Koji
    Fujino, Minoru
    Mizuuchi, Yusuke
    Hattori, Masami
    Miyazaki, Tetsuyuki
    Tanaka, Masao
    Oda, Yoshinao
    HISTOPATHOLOGY, 2014, 65 (03) : 389 - 397
  • [7] Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma
    Kanai, Tomoya
    Ito, Zensho
    Oji, Yusuke
    Suka, Machi
    Nishida, Sumiyuki
    Takakura, Kazuki
    Kajihara, Mikio
    Saruta, Masayuki
    Fujioka, Shuichi
    Misawa, Takeyuki
    Akiba, Tadashi
    Yanagisawa, Hiroyuki
    Shimodaira, Shigetaka
    Okamoto, Masato
    Sugiyama, Haruo
    Koido, Shigeo
    ONCOLOGY LETTERS, 2018, 16 (02) : 2682 - 2692
  • [8] Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma
    Qiu, Zhaoyan
    Chu, Yi
    Xu, Bing
    Wang, Qian
    Jiang, Mingzuo
    Li, Xiaowei
    Wang, Gang
    Yu, Pengfei
    Liu, Guoxiao
    Wang, Hua
    Kang, Huijie
    Liu, Jiayu
    Zhang, Yu
    Jin, Jian-Ping
    Wu, Kaichun
    Liang, Jie
    ONCOTARGET, 2017, 8 (34) : 56428 - 56442
  • [9] The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation
    Lüttges, J
    Schemm, S
    Vogel, I
    Hedderich, J
    Kremer, B
    Klöppel, G
    JOURNAL OF PATHOLOGY, 2000, 191 (02) : 154 - 161
  • [10] Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma
    Amit Mahipal
    Mary J. Mcdonald
    Agnieszka Witkiewicz
    Brian I. Carr
    Medical Oncology, 2012, 29 : 134 - 139